EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort

Dantong Zhu, Stephen T Vernon, Zac D'Agostino, Jingqin Wu iD, Corey Giles iD, Adam S Chan, Katharine A Kott iD, Michael P Gray iD, Alireza Gholipour, Owen Tang iD, Habtamu B Beyene iD, Ellis Patrick und 4 weitere

Biomolecules · 2023

DOI: 10.3390/biom13060917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Dantong Zhu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Statistics, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Coronary Artery Disease, Plaque, Atherosclerotic, Myocardial Infarction. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council Practitioner Fellowship, Investigator grant, Center of Research Excellence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current coronary artery disease (CAD) risk scores for predicting future cardiovascular events rely on well-recognized traditional cardiovascular risk factors derived from a population level but often fail individuals, with up to 25% of first-time heart attack patients having no risk factors. Non-invasive imaging technology can directly measure coronary artery plaque burden. With an advanced lipidomic measurement methodology, for the first time, we aim to identify lipidomic biomarkers to enable intervention before cardiovascular events. With 994 participants from BioHEART-CT Discovery Cohort, we collected clinical data and performed high-performance liquid chromatography with mass spectrometry to determine concentrations of 683 plasma lipid species. Statin-naive participants were selected based on subclinical CAD (sCAD) categories as the analytical cohort (n = 580), with sCAD+ (n = 243) compared to sCAD− (n = 337). Through a machine learning approach, we built a lipid risk score (LRS) and compared the performance of the existing Framingham Risk Score (FRS) in predicting sCAD+. We obtained individual classifiability scores and determined Body Mass Index (BMI) as the modifying variable. FRS and LRS models achieved similar areas under the receiver operating characteristic curve (AUC) in predicting the validation cohort. LRS enhanced the prediction of sCAD+ in the healthy-weight group (BMI < 25 kg/m2), where FRS performed poorly and identified individuals at risk that FRS missed. Lipid features have strong potential as biomarkers to predict CAD plaque burden and can identify residual risk not captured by traditional risk factors/scores. LRS compliments FRS in prediction and has the most significant benefit in healthy-weight individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePlaque, AtheroscleroticMyocardial InfarctionHumansLipidomicsCoronary AngiographyRisk AssessmentTomography, X-Ray ComputedBiomarkersLipids

Stichwörter der Autor:innen

CADimaging technologylipidomicstraditional risk factor

Substanzen

BiomarkersLipids

Autor:innen und Institutionen

  • School of Mathematics and Statistics, The University of Sydney, Sydney, NSW 2006, Australia.
  • Kolling Institute of Medical Research, The University of Sydney, Sydney, NSW 2065, Australia.
  • Department of Cardiology, Royal North Shore Hospital, Sydney, NSW 2065, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
  • Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Department of Cardiovascular Research Translation and Implementation, La Trobe University, Melbourne, VIC 3086, Australia.

ORCID-Profile: Jingqin Wu, Corey Giles, Katharine A Kott, Michael P Gray, Owen Tang, Habtamu B Beyene, Peter J Meikle

Förderung

  • National Health and Medical Research Council Practitioner Fellowship
  • Investigator grant
  • Center of Research Excellence

Zitieren

APA

Zhu, D., Vernon, S. T., D'Agostino, Z., Wu, J., Giles, C., Chan, A. S., Kott, K. A., Gray, M. P., Gholipour, A., Tang, O., Beyene, H. B., Patrick, E., Grieve, S. M., Meikle, P. J., Figtree, G. A., & Yang, J. Y. H. (2023). Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort. Biomolecules. https://doi.org/10.3390/biom13060917

Vancouver

Zhu D, Vernon ST, D'Agostino Z, Wu J, Giles C, Chan AS, et al. Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort. Biomolecules. 2023. doi:10.3390/biom13060917

BibTeX
@article{Zhu2023,
  author = {Zhu, Dantong and Vernon, Stephen T and D'Agostino, Zac and Wu, Jingqin and Giles, Corey and Chan, Adam S and Kott, Katharine A and Gray, Michael P and Gholipour, Alireza and Tang, Owen and Beyene, Habtamu B and Patrick, Ellis and Grieve, Stuart M and Meikle, Peter J and Figtree, Gemma A and Yang, Jean Y H},
  title = {Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13060917}
}
Kostenlos starten →